Back
Companhia De Saneamento Basico Do Estado De Sao Paulo Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
53
SBS
Companhia De Saneamento Basico Do Estado De Sao Paulo
Last Price:
13.90
Seasonality Move:
0.31%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.81
Seasonality Move:
-0.9%
Buy
53
Companhia De Saneamento Basico Do Estado De Sao Paulo (SBS)
is a Buy
Is Companhia De Saneamento Basico Do Estado De Sao Paulo a Buy, Sell or Hold?
- The current Companhia De Saneamento Basico Do Estado De Sao Paulo [SBS] share price is $14.19. The Score for SBS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SBS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SBS Stock Price Chart
What is Companhia De Saneamento Basico Do Estado De Sao Paulo's stock price today?
-
The Companhia De Saneamento Basico Do Estado De Sao Paulo share price today is $14.19
The current trend is relatively stagnant and SBS is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
SBS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 48.58 | Sell |
Chaikin Money Flow: | -512278 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.71 - 14.65) | Buy |
Bollinger Bands (100): | (14.62 - 16.34) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.7 | Sell |
Relative Strength Index (14 RSI): | 46.74 | Sell |
Chaikin Money Flow: | 84619 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Sell |
Bollinger Bands (100): | (40.86 - 48.8) | Sell |
SBS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.8 | Buy |
20-day SMA: | 14.04 | Buy |
50-day SMA: | 14.91 | Sell |
200-day SMA: | 14.45 | Sell |
8-day EMA: | 13.93 | Buy |
20-day EMA: | 14.12 | Buy |
50-day EMA: | 14.69 | Sell |
200-day EMA: | 14.31 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.53 | Buy |
20-day SMA: | 40.36 | Sell |
50-day SMA: | 41.57 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.71 | Buy |
20-day EMA: | 40.38 | Sell |
50-day EMA: | 41.84 | Sell |
200-day EMA: | 43.38 | Sell |
Companhia De Saneamento Basico Do Estado De Sao Paulo Earnings Growth & SBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.17 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Companhia De Saneamento Basico Do Estado De Sao Paulo Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |